Five companies have now been picked by the Trump administration as the most likely candidates to produce a coronavirus vaccine, The New York Times reports. This comes as part of Operation Warp Speed (OWS), the administration’s national program to accelerate the development, manufacturing, and distribution of COVID-19 vaccines, therapeutics, and diagnostics. Among its other objectives, Operation Warp Speed aims to …

Pharmaceutical companies are preparing to test their coronavirus vaccines on tens of thousands of people this summer. The fast-moving process has garnered an optimistic outlook from Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, who said on Tuesday that the US could have hundreds of millions of approved vaccines by 2021. Moderna will begin giving …

It is not possible to develop a vaccine for Covid-19 soon, as the RNA virus changes very quickly and this makes it difficult to create a good vaccine, says Claudio Colosio Unimi Professor, Department of Health Sciences University of Milan, Italy. Claudio as the Director, Occupational Health Unit of the Hospitals Saints Paolo and Carlo of Milano, has been extensively …

CoronavirusNOW: Live updates on the COVID-19 pandemic Special coverage of the COVID-19 public health crisis, including breaking news from around the country, exclusive interviews with health officials and live content from a variety of public health resources and press conferences. Produced by FOX Television Stations, this stream includes content from local FOX affiliates, FOX News, FOX Business and FOX Sports. …

The Trump administration has picked five COVID-19 vaccine candidates that it views as the most likely to be successful, according to an article published Wednesday by The New York Times. The newspaper stated that four of the companies whose candidates made the list are U.S.-based: Moderna (NASDAQ:MRNA), Johnson & Johnson (NYSE:JNJ), Merck (NYSE:MRK), and Pfizer (NYSE:PFE). The other is U.K.-headquartered AstraZeneca …

In a phone interview with CNN Wednesday, Fauci noted that children tend to have milder symptoms or even no symptoms when they are infected with Covid-19. What’s not yet clear is whether children get infected as frequently as adults, and whether they often pass the infection on to others. Ultimately, he said, the decision to reopen schools needs to be …

An anti-malaria drug that has been trumpeted as a therapy for COVID-19 was unable in a University of Minnesota clinical trial to prevent the onset of the infectious disease. The results of the nation’s first randomized trial with the drug, hydroxychloroquine, against COVID-19 will disappoint doctors who had hoped for new therapies amid the pandemic. Many prescribers had given it …

The Trump administration has selected five companies, including Moderna Inc, AstraZeneca Plc and Pfizer Inc, as the most likely candidates to produce a vaccine for the novel coronavirus, the New York Times reported on Wednesday, citing senior officials. The other two companies are Johnson & Johnson and Merck & Co Inc, according to the paper https://www.nytimes.com/2020/06/03/us/politics/coronavirus-vaccine-trump-moderna.html. The selected companies will …

A spike in demand for anxiety and depression drugs has led to shortages of some forms of the commonly used antidepressant Zoloft and its generic, sertraline. Reports of the shortage, posted Friday on the Food and Drug Administration’s website, come as a new survey published Wednesday from the Johns Hopkins University shows a major increase in the feelings of distress …

President Trump said he took hydroxychloroquine last month, shortly after he found out that his personal valet had been diagnosed with the coronavirus. The University of Minnesota study has been covered in the media over the past few months, and Dr. David Boulware, the author of the new study, says the president’s physician sent him an email on May 9, …